Suppr超能文献

加巴喷丁治疗三叉神经痛的疗效:随机对照试验的系统评价

Efficacy of gabapentin in the treatment of trigeminal neuralgia: A systematic review of randomized controlled trials.

作者信息

Ta Patrick Chieu Poa, Dinh Hue Quyen, Nguyen Kim, Lin Samuel, Ong Yong Li, Ariyawardana Anura

机构信息

College of Medicine and Dentistry, James Cook University, Cairns, QLD, Australia.

Metro South Oral Health, Queensland Health, Brisbane, QLD, Australia.

出版信息

J Investig Clin Dent. 2019 Nov;10(4):e12448. doi: 10.1111/jicd.12448. Epub 2019 Aug 11.

Abstract

The aim of this systematic review was to determine the efficacy of gabapentin (GBP) in the treatment of pain of  idiopathic trigeminal neuralgia (TN). A comprehensive literature search was conducted using the Cumulative Index of Nursing and Allied Health Literature (EBSCO Industries), Emcare (Ovid), Medline (Ovid), Medline (PubMed), Scopus (Elsevier) and Web of Science (Clarivate Analytics). The inclusion criteria comprised randomized controlled trials of GBP as a monotherapy in the treatment of idiopathic TN in adult participants and publications in English. All other study methodologies were excluded. The search yielded 1472 articles, and after exclusion, 11 full-text articles were eligible for full-text analysis. Only two studies met the inclusion criteria. There is insufficient evidence either to support or refute the efficacy of GBP in the management of idiopathic TN. Therefore, further well-designed placebo-controlled trials are required to confirm the efficacy of GBP in managing TN pain as a single therapy.

摘要

本系统评价的目的是确定加巴喷丁(GBP)治疗特发性三叉神经痛(TN)疼痛的疗效。使用护理及相关健康文献累积索引(EBSCO Industries)、Emcare(Ovid)、Medline(Ovid)、Medline(PubMed)、Scopus(爱思唯尔)和科学网(科睿唯安分析)进行了全面的文献检索。纳入标准包括GBP作为单一疗法治疗成年特发性TN参与者的随机对照试验以及英文出版物。排除所有其他研究方法。检索得到1472篇文章,排除后,有11篇全文文章符合全文分析要求。只有两项研究符合纳入标准。目前尚无足够证据支持或反驳GBP治疗特发性TN的疗效。因此,需要进一步设计良好的安慰剂对照试验来证实GBP作为单一疗法治疗TN疼痛的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验